» Articles » PMID: 131783

Immune Mechanism in Pasteurella Multocida-infected Mice

Overview
Journal Infect Immun
Date 1976 Mar 1
PMID 131783
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Various immunizing procedures were tested for their effect on the growth of Pasteurella multocida in specific pathogen-free CD-1 mice. Two injections with killed vaccine incorporated into Freund complete adjuvant gave excellent protection against parenteral challenge, but less to control the growth of an aerogenic inoculum. Protection with adjuvant-treated preparation was always superior to that seen with non-adjuvant-treated vaccines. A killed saline-suspended vaccine introduced aerogenically marginally increased resistance to small (2 to 5 mean lethal doses) aerogenic challenges. Live mycobacterium bovis (BCG) vaccine immunopotentiated a single dose of heat-killed P. multocida vaccine in terms of the protective immune response against a subsequent footpad challenge. Hyperimmune mouse serum, administered intraperitoneally, intramuscularly, or intravenously 1 to 7 days prior to subcutaneous challenge with 500 to 5,000 P. multocida, was highly protective. Mice injected in the thigh with 0.2 ml of hyperimmune serum prior to footpad challenge frequently developed a severe inflammatory response with local swelling within 48 h; these lesions often became severly abscessed with time. The passively protected, footpad-infected mice developed active immunity against a subsequent challenge given into the opposite footpad.

Citing Articles

Rapidly progressive and lethal septicemia due to infection with Pasteurella multocida in an infant.

Haybaeck J, Schindler C, Braza P, Willinger B, Drlicek M Wien Klin Wochenschr. 2009; 121(5-6):216-9.

PMID: 19412752 DOI: 10.1007/s00508-009-1147-1.


Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

Vasfi Marandi M, Mittal K Infect Immun. 1997; 65(11):4502-8.

PMID: 9353026 PMC: 175647. DOI: 10.1128/iai.65.11.4502-4508.1997.


Bactericidal activity of alveolar and peritoneal macrophages exposed in vitro to three strains of Pasteurella multocida.

Collins F, Niederbuhl C, Campbell S Infect Immun. 1983; 39(2):779-84.

PMID: 6832820 PMC: 348017. DOI: 10.1128/iai.39.2.779-784.1983.


Hyperimmune serum from rabbits immunized with potassium thiocyanate extract of Pasteurella multocida protects against homologous challenge.

Lu Y, Pakes S, Massey L J Clin Microbiol. 1987; 25(11):2173-80.

PMID: 3693546 PMC: 269435. DOI: 10.1128/jcm.25.11.2173-2180.1987.


Antibodies to outer membrane proteins but not to lipopolysaccharide inhibit pulmonary proliferation of Pasteurella multocida in mice.

Lu Y, Aguila H, Lai W, Pakes S Infect Immun. 1991; 59(4):1470-5.

PMID: 2004825 PMC: 257865. DOI: 10.1128/iai.59.4.1470-1475.1991.


References
1.
Collins F, MONTALBINE V . Relative immunogenicity of streptomycin-susceptible and -resistant strains of BCG. II. Effect of the route of inoculation on growth and immunogenicity. Am Rev Respir Dis. 1975; 111(1):43-51. DOI: 10.1164/arrd.1975.111.1.43. View

2.
Reynolds H, Thompson R . Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa. J Immunol. 1973; 111(2):358-68. View

3.
Lillie L, Thomson R . The pulmonary clearance of bacteria by calves and mice. Can J Comp Med. 1972; 36(2):129-37. PMC: 1319632. View

4.
Collins F . Effect of adjuvant on immunogenicity of a heat-killed salmonella vaccine. J Infect Dis. 1972; 126(1):69-76. DOI: 10.1093/infdis/126.1.69. View

5.
Miller T, Mackaness G, Lagrange P . Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst. 1973; 51(5):1669-76. DOI: 10.1093/jnci/51.5.1669. View